Matches in Wikidata for { <http://www.wikidata.org/entity/Q67128044> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q67128044 description "clinical trial" @default.
- Q67128044 description "ensayu clínicu" @default.
- Q67128044 description "klinisch onderzoek" @default.
- Q67128044 description "клінічне випробування" @default.
- Q67128044 name "Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmon" @default.
- Q67128044 name "Non Inferiority of Fixed Combination of Beclomethasone Dipropionate" @default.
- Q67128044 type Item @default.
- Q67128044 label "Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmon" @default.
- Q67128044 label "Non Inferiority of Fixed Combination of Beclomethasone Dipropionate" @default.
- Q67128044 prefLabel "Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmon" @default.
- Q67128044 prefLabel "Non Inferiority of Fixed Combination of Beclomethasone Dipropionate" @default.
- Q67128044 P1132 Q67128044-F269C0C5-84AB-4A1C-9890-38571865C6C4 @default.
- Q67128044 P1476 Q67128044-92B27083-2ECA-4781-800F-CE151C5C03FA @default.
- Q67128044 P17 Q67128044-10C44116-8B03-4B2E-9AEE-BC2D732E7BE9 @default.
- Q67128044 P2899 Q67128044-F8698FAA-3614-410E-BA0F-814C62FC86AD @default.
- Q67128044 P3098 Q67128044-58143236-A39F-4782-B9DE-D292F711C614 @default.
- Q67128044 P31 Q67128044-54CE71E5-0504-4E5C-947C-4A3F863F06FC @default.
- Q67128044 P4844 Q67128044-05D2924A-A948-46D8-B4D5-2FC1E45BF841 @default.
- Q67128044 P4844 Q67128044-5FE277FE-3906-443B-978A-5D862C5DB928 @default.
- Q67128044 P580 Q67128044-3B6DCFDC-6C64-4697-A5E2-5FC586D36E9F @default.
- Q67128044 P582 Q67128044-12F09217-DB09-4FB2-B159-9A29D4021609 @default.
- Q67128044 P6099 Q67128044-59EE10F5-F230-4FA9-B2D0-82592B12278E @default.
- Q67128044 P8363 Q67128044-90866C0F-6EA1-440F-9BD7-5BFDADEE1D50 @default.
- Q67128044 P1132 "+1479" @default.
- Q67128044 P1476 "A Multinational, Multicentre, Randomised, Open-Label, Active-Controlled, 26-Week, 2-Arm, Parallel Group Study to Evaluate the Non-Inferiority of Fixed Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate Plus Glycopyrronium Bromide (CHF 5993) Administered Via Pressurized Metered-dose Inhaler (pMDI) Versus Fixed Combination Of Fluticasone Furoate Plus Vilanterol Administered Via Dry Powder Inhaler (DPI) (Relvar®) Plus Tiotropium Bromide (Spiriva®) for the Treatment of Patients With Chronic Obstructive Pulmonary Disease" @default.
- Q67128044 P17 Q28 @default.
- Q67128044 P2899 "+40" @default.
- Q67128044 P3098 "NCT02467452" @default.
- Q67128044 P31 Q30612 @default.
- Q67128044 P4844 Q27132391 @default.
- Q67128044 P4844 Q411917 @default.
- Q67128044 P580 "2015-05-01T00:00:00Z" @default.
- Q67128044 P582 "2017-01-01T00:00:00Z" @default.
- Q67128044 P6099 Q42824827 @default.
- Q67128044 P8363 Q78089383 @default.